赛升药业：K11项目已进入Ⅲ期临床试验阶段，启动了70余家研究中心进行试验，预计年底前完成全部入组

Group 1 - The core viewpoint of the article is that Sai Sheng Pharmaceutical's K11 project has entered the Phase III clinical trial stage, with over 70 research centers initiated for the trial [2] - The company has stated that it expects to complete all patient enrollment by the end of the year, indicating that the project is progressing normally [2]